BioCentury
ARTICLE | Financial News

Aptalis rumored to be planning IPO after lack of bidder

October 25, 2013 1:10 AM UTC

Gastrointestinal company Aptalis Pharma Inc. (Mont-Saint-Hilaire, Quebec) could not be reached for comment on rumors that the company hired Goldman Sachs and JPMorgan and is planning an IPO slated for next year. According to Reuters, the move comes after private equity firm TPG was unable to secure a bidder to acquire Aptalis. TPG acquired Aptalis (formerly Axcan Pharma Inc.) in 2008 for around $1.3 billion. The banks and TPG declined to comment. ...